Andre Goy, MD, discusses the clinical implications of CAR T-cell therapy in mantle cell lymphoma.
Andre H. Goy, MD
Advertisement
Articles by Andre H. Goy, MD
Andre H. Goy, MD, discusses the potential utility of BTK inhibitors as maintenance therapy in mantle cell lymphoma.
Advertisement
Latest Updated Articles
Dr. Goy on the Potential Utility of BTK Inhibitors as Maintenance in MCLPublished: May 10th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Thoughts on Reducing Costs of Goods
4
Quarter Century Update: Future Predictions for the Field
5
